Skip to main content

Paige Mahaney, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CCCC alerts

About Paige Mahaney, Ph.D.

C4 Therapeutics, Inc. reported in an 8-K filed October 15, 2024 that Paige Mahaney, Ph.D. was appointed Chief Scientific Officer, effective October 28, 2024. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.

“On October 15, 2024, the Company announced the appointment of Paige Mahaney, Ph.D. as its Chief Scientific Officer, effective as of October 28, 2024.”
C4 Therapeutics, Inc. Form 8-K, filed October 15, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at C4 Therapeutics, Inc.

Recent activity